These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25971916)

  • 21. Bioconjugation using mutant glycosyltransferases for the site-specific labeling of biomolecules with sugars carrying chemical handles.
    Ramakrishnan B; Boeggeman E; Pasek M; Qasba PK
    Methods Mol Biol; 2011; 751():281-96. PubMed ID: 21674337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.
    Griffiths GL; Chang CH; McBride WJ; Rossi EA; Sheerin A; Tejada GR; Karacay H; Sharkey RM; Horak ID; Hansen HJ; Goldenberg DM
    J Nucl Med; 2004 Jan; 45(1):30-9. PubMed ID: 14734668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
    Velikyan I; Sundberg AL; Lindhe O; Höglund AU; Eriksson O; Werner E; Carlsson J; Bergström M; Långström B; Tolmachev V
    J Nucl Med; 2005 Nov; 46(11):1881-8. PubMed ID: 16269603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dienophile-Modified Mannosamine Derivatives for Metabolic Labeling of Sialic Acids: A Comparative Study.
    Dold JEGA; Pfotzer J; Späte AK; Wittmann V
    Chembiochem; 2017 Jul; 18(13):1242-1250. PubMed ID: 28318083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting specificity and pharmacokinetics of asialoorosomucoid, a specific ligand for asialglycoprotein receptor on hepatocyte.
    Yang DY; Ouyang CH; Lu FG; Liu XW; Huang LQ
    J Dig Dis; 2007 May; 8(2):89-95. PubMed ID: 17532821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA.
    Altai M; Strand J; Rosik D; Selvaraju RK; Eriksson Karlström A; Orlova A; Tolmachev V
    Bioconjug Chem; 2013 Jun; 24(6):1102-9. PubMed ID: 23705574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
    Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography.
    Shetty D; Jeong JM; Ju CH; Kim YJ; Lee JY; Lee YS; Lee DS; Chung JK; Lee MC
    Bioorg Med Chem; 2010 Nov; 18(21):7338-47. PubMed ID: 20926300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and characterization of a high-affinity NOTA-conjugated bombesin antagonist for GRPR-targeted tumor imaging.
    Varasteh Z; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Sandström M; Selvaraju RK; Malmberg J; Tolmachev V; Orlova A
    Bioconjug Chem; 2013 Jul; 24(7):1144-53. PubMed ID: 23763444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
    Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of POLARIC™ fluorophores in an in vivo tumor model.
    Maishi N; Kawamoto T; Ohga N; Yamada K; Akiyama K; Yamamoto K; Osawa T; Hida Y; Hida K
    Oncol Rep; 2013 Oct; 30(4):1695-700. PubMed ID: 23877868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
    J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of desialylation during 2-amino benzamide labeling of asparagine-linked oligosaccharides.
    Aich U; Hurum DC; Basumallick L; Rao S; Pohl C; Rohrer JS; Kandzia S
    Anal Biochem; 2014 Aug; 458():27-36. PubMed ID: 24657360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (68)Ga-labeled 3PRGD2 for dual PET and Cerenkov luminescence imaging of orthotopic human glioblastoma.
    Fan D; Zhang X; Zhong L; Liu X; Sun Y; Zhao H; Jia B; Liu Z; Zhu Z; Shi J; Wang F
    Bioconjug Chem; 2015 Jun; 26(6):1054-60. PubMed ID: 25853280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomolecular labeling based on lysine-clickable 6π-azaelectrocyclization toward innovative cancer theranostics.
    Fujiki K; Tanaka K
    Bioorg Med Chem; 2021 Jul; 42():116238. PubMed ID: 34082394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. I: Radiochemical and animal distribution studies.
    Galli G; Maini CL; Orlando P; Deleide G; Valle G
    J Nucl Med Allied Sci; 1988; 32(2):110-6. PubMed ID: 3049961
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
    Wei L; Butcher C; Miao Y; Gallazzi F; Quinn TP; Welch MJ; Lewis JS
    J Nucl Med; 2007 Jan; 48(1):64-72. PubMed ID: 17204700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.